-
The treatment approved by NICE combines a technique called photodynamic therapy (PDT) with a drug called Visudyne.
BBC: NEWS | Health | Row over blindness treatment delay
-
One was Visudyne (verteporfin), the first drug treatment for severe forms of macular degeneration, the leading cause of blindness.
FORBES: Reviving Novartis
-
Aside from Macugen, Visudyne, from Novartis and QLT is available to treat AMD.
FORBES: Magazine Article
-
Verteporfin, marketed by the drug firm Novartis as Visudyne, aims to stop the progressive loss of vision associated with wet AMD.
BBC: Blindness therapy row
-
Unlike the newer drugs, Visudyne is injected intravenously, not into the eye.
FORBES: Magazine Article
-
The Visudyne dye, which is manufactured by drug company CIBA UK, was approved by the European Medicines Evaluation Agency four weeks ago after being tested in two 12-month clinical trials.
BBC: Treatment 'will reverse blindness'
-
And how will both fare against other treatments, such as Visudyne, the gold standard from QLT Therapeutics (nasdaq: QLTI - news - people ) and Novartis (nyse: NVS - news - people ) and Alcon 's (nyse: ALC - news - people ) experimental Retaane.
FORBES: Pfizer Vs. Genentech